CD8A and neoplasm: In fact, priming with a DNA vaccine in the presence of α-GalCer and boosting with E7-pulsed DC led to a significant enhancement of E7-specific CD8(+) effector and memory T-cells as well as significantly improved therapeutic effects against an E7-expressing tumor model (TC-1) in vaccinated mice [28].